Regulation of glycolysis and the Warburg effect by estrogen-related receptors

Oncogene

Volumn 32, Issue 16, 2013, Pages 2079-2086

  Cai, Q ^a   Lin, T ^a   Kamarajugadda, S ^a   Lu, J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

aerobic glycolysis; nuclear receptor; Randle cycle; Warburg effect

Indexed keywords

ESTROGEN RELATED RECEPTOR ALPHA; LACTIC ACID; MYC PROTEIN;

AEROBIC METABOLISM; ARTICLE; CELL GROWTH; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION; GENE OVEREXPRESSION; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; WARBURG EFFECT;

ADENOSINE TRIPHOSPHATE; AEROBIOSIS; ANIMALS; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; GLUCOSE; GLYCOLYSIS; HEK293 CELLS; HUMANS; LACTIC ACID; MCF-7 CELLS; MICE; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, ESTROGEN; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84876693212     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.221     Document Type: Article

References (34)

1. Koppenol WH, Bounds PL, Dang CV. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011; 11: 325-337.
2. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324: 1029-1033.
3. Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet 2011; 43: 869-874.
4. Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 2011; 476: 346-350.
5. Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008; 13: 472-482.
6. Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell 2008; 134: 703-707.
7. Dang CV, Kim JW, Gao P, Yustein J. The interplay between MYC and HIF in cancer. Nat Rev Cancer 2008; 8: 51-56.
8. Tennant DA, Durán RV, Gottlieb E. Targeting metabolic transformation for cancer therapy. Nat Rev Cancer 2010; 10: 267-277.
9. Levine AJ, Puzio-Kuter AM. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 2010; 330: 1340-1344.
10. Semenza GL. Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin Cancer Biol 2009; 19: 12-16.
11. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006; 3: 177-185.
12. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 2006; 3: 187-197.
13. Semenza GL. Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. Biochem Biophys Acta 2011; 1813: 1263-1268.
14. Kim JW, Zeller KI, Wang Y, Jegga AG, Aronow BJ, O'Donnell KA et al. Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immuno-precipitation assays. Mol Cell Biol 2004; 24: 5923-5936.
15. Ao A, Wang H, Kamarajugadda S, Lu J. Involvement of estrogen-related receptors in transcriptional response to hypoxia and growth of solid tumors. Proc Natl Acad Sci USA 2008; 105: 7821-7826.
16. Giguère V. Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr Rev 2008; 29: 677-696.
17. Hock MB, Kralli A. Transcriptional control of mitochondrial biogenesis and function. Annu Rev Physiol 2009; 71: 177-203.
18. Hue L, Taegtmeyer H. The Randle cycle revisited: a new head for an old hat. Am J Physiol Endocrinol Metab 2009; 297: E578-E591.
19. Wende AR, Huss JM, Schaeffer PJ, Giguère V, Kelly DP. PGC-1alpha coactivates PDK4 gene expression via the orphan nuclear receptor ERRalpha: a mechanism for transcriptional control of muscle glucose metabolism. Mol Cell Biol 2005; 25: 10684-10694.
20. Zhang Y, Ma K, Sadana P, Chowdhury F, Gaillard S, Wang F et al. Estrogen-related receptors stimulate pyruvate dehydrogenase kinase isoform 4 gene expression. J Biol Chem 2006; 281: 39897-39906.
21. Araki M, Motojima K. Identification of ERRalpha as a specific partner of PGC-1alpha for the activation of PDK4 gene expression in muscle. FEBS J 2006; 273: 1669-1680.
22. Dufour BJ, Wilson JM, Huss DP, Kelly WA, Alaynick M, Downes RM et al. Genone-wide orchestration of cardiac functions by orphan nucler receptors ERRa and g. Cell Metab 2007; 5: 345-356.
23. Deblois JA, Hall MC, Perry J, Laganière M, Ghahremani M, Park M et al. Genome-wide identification of direct target genes implicates estrogen-related receptor a as a determinant of breast cancer heterogeneity. Cancer Res 2009; 69: 6149-6157.
24. Charest-Marcotte CR, Dufour BJ, Wilson AM, Tremblay LJ, Eichner DH, Arlow VK et al. The homeobox protein Prox1 is a negative modulator of ERRa/PGC-1a bioenergetic functions. Genes Dev 2010; 24: 537-542.
25. Tennessen JM, Baker KD, Lam G, Evans J, Thummel CS. The Drosophila estrogen-related receptor directs a metabolic switch that supports developmental growth. Cell Metab 2011; 13: 139-148.
26. Ariazi EA, Jordan VC. Estrogen-related receptors as emerging targets in cancer and metabolic disorders. Curr Top Med Chem 2006; 6: 203-215.
27. Chang CY, Kazmin D, Jasper JS, Kunder R, Zuercher WJ, McDonnell DP. The metabolic regulator ERRa, a downstream target of HER2/IGF-1R, as a therapeutic target in breast cancer. Cancer Cell 2011; 20: 500-510.
28. Stein RA, Chang CY, Kazmin DA, Way J, Schroeder T, Wergin M et al. Estrogen-related receptor a is critical for the growth of estrogen receptor-negative breast cancer. Cancer Res 2008; 68: 8805-8812.
29. Wu M, Neilson A, Swift AL, Moran R, Tamagnine J, Parslow D et al. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioe-nergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol 2007; 292: C125-C136.
30. Hardie DG. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev 2011; 25: 1895-1908.
31. Jose C, Bellance N, Rossignol R. Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma? Biochem Biophys Acta 2011; 1807: 552-561.
32. Eichner LJ, Perry MC, Dufour CR, Bertos N, Park M, St-Pierre J et al. mir-378* mediates metabolic shift in breast cancer cells via the PGC-1b/ERRg transcrip-tional pathway. Cell Metab 2010; 12: 352-361.
33. Li F, Wang Y, Zeller KI, Potter JJ, Wonsey DR, O'Donnell KA et al. Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol Cell Biol 2005; 25: 6225-6234.
34. Dang CV, Le A, Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res 2009; 15: 6479-6483.